Skip to content

Explore multiple analgesic regimens of integrated traditional Chinese and western medicine: single-blind, randomized, multicenter, phase II clinical study

Explore multiple analgesic regimens of integrated traditional Chinese and western medicine: single-blind, randomized, multicenter, phase II clinical study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000004032
Enrollment
Unknown
Registered
2020-08-29
Start date
2020-09-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer, pancreatic cancer, esophageal cancer

Interventions

Sponsors

Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18 to 70 years old male or female; (2) the patients were mainly diagnosed as lung cancer, pancreatic cancer and esophageal cancer by histo athological biopsy; (3) the estimated survival time is more than 3 months; (4) have tumor-related pain and be able to score cancer pain independently; (5) the corresponding painkillers have been taken according to the three-step analgesic method, and the cancer pain is basically stable; (6) the patients and their families can have good communication skills, voluntarily participate in this trial and sign a written informed consent form. Be able to adhere to and follow the requirements of the program.

Exclusion criteria

Exclusion criteria: (1) patients with pain caused by other non-cancerous factors; (2) patients have severe or uncontrolled systemic diseases or diseases that researchers believe are not suitable for patients to participate in the trial, including skin diseases (such as local skin ulceration of the auricle or those with a history of skin allergy not suitable for auricular point application), severe hypertension, heart disease and so on; (3) pregnant and lactating women; (4) it is determined by the researchers that it is not suitable for patients to participate in this trial.

Design outcomes

Primary

MeasureTime frame
Pain NRS score;Incidence and remission of adverse reactions during treatment;Quality of life score of tumor patients;The frequency and duration of the outbreak of pain, the relief time of rescue dose and the degree of pain relief.;Changes in oral dose of painkillers;

Countries

China

Contacts

Public ContactWen qinglian

Affiliated Hospital of Southwest Medical University

wql7311@hotmail.com+86 13518388130

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026